ArticleFrontiers in immunology2021

An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer.

Changfang Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.